Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.945 USD | -1.56% |
|
+1.68% | -24.18% |
Jul. 01 | Akebia Therapeutics, Inc.(NasdaqCM:AKBA) added to Russell 3000 Index | CI |
Jul. 01 | Akebia Therapeutics, Inc.(NasdaqCM:AKBA) added to Russell 3000E Value Index | CI |
Financials (USD)
Sales 2024 * | 173M | Sales 2025 * | 159M | Capitalization | 201M |
---|---|---|---|---|---|
Net income 2024 * | -64M | Net income 2025 * | -73M | EV / Sales 2024 * | 1.17 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.26 x |
P/E ratio 2024 * |
-3.69
x | P/E ratio 2025 * |
-2.94
x | Employees | 167 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.73% |
Latest transcript on Akebia Therapeutics, Inc.
1 day | -1.56% | ||
1 week | +1.68% | ||
Current month | -7.82% | ||
1 month | -17.53% | ||
3 months | -36.90% | ||
6 months | -31.37% | ||
Current year | -24.18% |
![Extreme 0.9129](/images/extremecours_fleche.png)
![Extreme 0.8](/images/extremecours_fleche.png)
![Extreme 0.8](/images/extremecours_fleche.png)
![Extreme 0.7801](/images/extremecours_fleche.png)
![Extreme 0.241](/images/extremecours_fleche.png)
![Extreme 0.241](/images/extremecours_fleche.png)
![Extreme 0.241](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
John Butler
CEO | Chief Executive Officer | 59 | 13-06-30 |
Tracey Vetterick
ADM | Chief Administrative Officer | - | 22-03-31 |
Steven Burke
CTO | Chief Tech/Sci/R&D Officer | 63 | 19-06-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Rogers
BRD | Director/Board Member | 64 | 18-12-11 |
Adrian Adams
CHM | Chairman | 73 | 18-12-11 |
LeAnne Zumwalt
BRD | Director/Board Member | 65 | 21-02-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-03 | 0.9434 | -1.73% | 859 551 |
24-07-02 | 0.96 | -3.46% | 3,298,198 |
24-07-01 | 0.9944 | -2.51% | 4,350,843 |
24-06-28 | 1.02 | +3.11% | 25,512,146 |
24-06-27 | 0.9892 | +6.98% | 7,758,374 |
Delayed Quote Nasdaq, July 03, 2024 at 11:14 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.18% | 201M | |
+14.95% | 122B | |
+15.92% | 113B | |
+17.29% | 26.22B | |
-24.32% | 19.01B | |
-19.14% | 15.71B | |
-18.51% | 15.22B | |
-47.37% | 14.72B | |
+58.74% | 14.58B | |
+4.77% | 13.84B |
- Stock Market
- Equities
- AKBA Stock